Partners4Access

Partners4Access (P4A) is a consultancy that focuses on market access for orphan drugs, gene therapies, and other rare disease treatments. The company offers solutions to assist with pricing, reimbursement, and market access strategies.
  • RarePulse
  • Access Strategy
  • Digital Solutions
  • Price Optimisation
  • Value Communication
  • Launch Success Model

Size
Small
Phone
+31 6 55 88 71 96
Email
N/A
Locations
70 St Mary Axe, EC3A 8BE
Digital Popularity
Social Media
Competitors
Access Infinity
Access Infinity provides consulting services and digital solutions focused on market access in the pharmaceutical industry.
Initiate Consultancy
Initiate Consultancy is a market access and health economics consultancy that crafts strategies to deliver reimbursed access for life-impacting diseases.
Akeso
Akeso is a specialist healthcare and life science consultancy dedicated to delivering meaningful and sustainable improvements through consulting and analytic offerings.
Company Details
Partners4Access is operated by Partners4access and is a Open company incorporated on 1 October 2016 with the registered office located in London, Greater London. Partners4access was registered 8 years ago.

Status
Open
Size
Micro
Directors
0
Age
8 years old
Employees
Unreported
Turnover
Unreported
Total Assets
Unreported
Cash in Bank
Unreported
Total Liabilities
Unreported

Teams
All
15
Management
7
Finance
7
Research
7
Other
1
Executive Director • Joined Nov 2023
Corporate Affairs Lead
Creative Director • Joined Dec 2020
Associate Consultant • Joined Dec 2024
Associate Consultant • Joined Apr 2023
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Consultant • Joined Jan 2025
Executive Director • Joined Nov 2023
Corporate Affairs Lead
Creative Director • Joined Dec 2020
Associate Consultant • Joined Dec 2024
Associate Consultant • Joined Apr 2023
Consultant • Joined Jan 2025
Consultant • Joined Jul 2024
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Senior Analyst • Joined Jul 2024
Senior Analyst • Joined Jul 2024
Senior Analyst • Joined Jul 2024
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Analyst • Joined Jan 2025
Senior Analyst • Joined Jul 2024
Senior Analyst • Joined Jul 2024
Senior Analyst • Joined Jul 2024
View 15 members